Long-term use of bisphosphonates in the treatment of HIV-related bone pain in perinatally infected pediatric patients

AIDS

Volumn 22, Issue 14, 2008, Pages 1888-1890

  Fortuny, Clàudia ^a   Noguera, Antoni ^a   Alsina, Laia ^a   Villaronga, Miquel ^a   Vidal Sicart, Sergi ^b   Sánchez, Emólia ^c  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c Catalan Agency for Health Technology Assessment and Research   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; ONDANSETRON; PAMIDRONIC ACID; PARACETAMOL; VITAMIN D;

BONE DENSITY; BONE PAIN; GASTROINTESTINAL DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHERMIA; LETTER; LONG TERM CARE; OSTEOLYSIS; OSTEOPOROSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADOLESCENT; BACK PAIN; BONE DENSITY CONSERVATION AGENTS; CHILD; COHORT STUDIES; DIPHOSPHONATES; FEMALE; HIV INFECTIONS; HUMANS; MALE; TIME;

EID: 66349131697     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32830c483c     Document Type: Letter

References (15)

1. Leonard EG, McComsey GA. Metabolic complications of HIV therapy in children. AIDS 2004; 18:1753-1768.
2. ArpadiS, HorlickM, Shane E. Metabolic bone disease in human immunodeficiency virus-infected children. J Clin Endocrinol Metab 2004; 89:21-23.
3. Rojo Conejo P, Ramos Amador JT, Garcia Pinar L, Ruano Fajardo C, Sánchez Granados JM, González Tome ́MI, et al. Decreased bone mineral density in HIV-infected children receiving highly active antiretroviral therapy. An Pediatr (Barc) 2004; 60:249-253.
4. Working Group on Antiretroviral Therapy and Medical Management of HIV-1-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV-1 Infection. Supplement III: pediatric adverse drug effects. February 28, 2008. Available at http://aidsinfo.nih.gov/ContentFiles/ PediatricGuidelines.pdf. Accessed on 20th May 2008, pp. 22-25.
5. Mondy K, Powderly WG, Claxton SA, Yarasheski KH, Royal M, Stoneman JS, et al. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J Acquir Immune Defic Syndr 2005; 38: 426-431.
6. McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, et al. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS 2007; 21:2473-2482.
7. Ward L, Tricco A, Phuong P, Cranney A, Barrowman N, Gaboury I, et al. Bisphosphonate therapy for children and adolescents with secondary osteoporosis. Cochrane Database Syst Rev 2007; 4:CD005324.
8. del Rio L, Carrascosa A, Pons F, Gusinye M, Yeste D, Domenech FM. Bone mineral density of the lumbar spine in white mediterranean Spanish children and adolescents: changes related to age, sex and puberty. Pediatr Res 1994; 35:362-366.
9. Ferrández-Longás A, Mayayo E, Labarta JI, Bague L, Puga B, RuedaC, et al. Estudio longitudinal decrecimientoy desarrollo. Centro Andrea Prader. Zaragoza 1980-2002. In: Patrones de crecimiento y desarrollo en España. Atlas de gráficas y tablas. Madrid: ERGON; 2004. pp. 61 -115.
10. MoraS, Zamproni I, BeccioS, Bianchi R, GiacometV, Vigano'A. Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children. J Clin Endocrinol Metab 2004; 89:24-28.
11. Mora S, Zamproni I, Cafarelli L, GiacometV, Erba P, Zuccotti G, et al. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents. AIDS 2007; 21:1129-1135.
12. Bianchi ML. Osteoporosis in children and adolescents. Bone 2007; 41:486-495.
13. Soler-Palacín P, Torrent A, Rossich R, Moraga FA, Yeste D, Carreno JC, et al. Osteoporosis and multiple fractures in an antiretroviral-naive, HIV-positive child. J Pediatr Endocrinol Metab 2007; 20:933-938.
14. González E, Pavía C, Ros J, Villaronga M, Valls C, Escola J. Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta. J Pediatr Endocrinol Metab 2001; 14:529-533.
15. Noguera A, RosJB, Pavía C, Alcover E, Valls C, Villaronga M, et al. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol Metab 2003; 16:529-536.